OHRP

Ohr Pharmaceutical Announces Initiation of Investigator Sponsored Trial of Squalamine Eye Drops in Diabetic Macular Edema

[GlobeNewswire] – NEW YORK — Ohr Pharmaceutical, Inc. , a research and development company with a primary focus in ophthalmology, today announced the initiation of a Phase II investigator sponsored clinical trial, OHR-005, … moreView todays social media effects on OHRPView the latest stocks trending across Twitter. Click to view dashboardSee who Ohr is hiring next, click here to view […]

Ohr Pharmaceutical and Cold Spring Harbor Laboratory Announce Joint Venture to Develop Trodusquemine and Related Analogs

[GlobeNewswire] – NEW YORK — Ohr Pharmaceutical , a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory … moreView todays social media effects on OHRPView the latest stocks trending across Twitter. Click to view dashboardSee who Ohr is hiring next, click here to view […]